Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News Complete Archive »

Musculoskeletal News Roundup 7-Jul-11 BY LAUREN UZDIENSKI, JULY 7, 2011

RSB Spine announced that 2Q:11 sales increased by 131% compared to 2Q:10 and by 20% compared to 1Q:11.

Apax France acquired Amplitude, a French large joint manufacturer, from Weinberg Capital Partners and Initiative & Finance (I&F). The deal values the company in the EUR 100.0-125.0 million ($143.8-$179.7 million) range. The company has EUR 46.0 million ($66.1 million) in revenue, 25% of which is generated outside of France through a German subsidiary and a distribution network across 25 countries.

NeuroTherm acquired the Parallax and Contour product lines used in interventional spine procedures from ArthroCare. CEO of NeuroTherm Larry Hicks said the new products, used in vertebroplasty, complement the company's "existing competencies in interventional pain management, allowing us to leverage our clinical expertise and strong sales channels." Financial terms were not disclosed.

Stryker closed its acquisition of Memometal Technologies. The company manufactures and markets products made from a shape-memory metal alloy for extremity indications.

SpineVision raised $5.0 million in a round led by Partner Capital, Sofinnova, BroadPeak, HealthCap, Innoven and Edbi. Funds will be used to "accelerate market penetration" of the company's MIS LUMIS system and the motion-preservation hybrid-rod system Flex+.

OMNIlife science received 510(k) clearance for its Apex PS Knee, which the company says "maintains the key design elements of the existing Apex Cruciate Retaining (CR) Knee but offers the post and cam system preferred by surgeons who utilize a posterior stabilized knee replacement." The new design was introduced into the European market in 2H:10, and a full U.S. launch is expected by the end of 2011.

Product Introduction and Update
Ascension Orthopedics launched the TITAN Inset Mini Glenoid, a new addition to the TITAN Modular Shoulder System. The company notes that the device allows for retention of soft tissues that would normally be resected with a standard glenoid, such as a healthy labrum.

Medtronic launched the CD HORIZON Fenestrated Screw Spinal System in Europe, with the release to be expanded to India, Singapore and Australia in the coming months. The system features a pedicle screw with additional holes in the tip to allow the company's specially-formulated bone cement to be injected into the vertebral body. The system, which is designed for use in patients with poor bone quality, is not available in the United States.

Olympus Biotech launched its BMP-7 product in Europe. The product was known as OP-1 when manufactured by Stryker, but has been renamed Opgenra. The device is indicated for posterolateral lumbar spinal Fusion in adult patients with spondylolisthesis where autograft has failed or is contraindicated.

RTI Biologics introduced two products this week. The first is the BioAdapt DBM Foam, which is offered in five pre-shaped options to meet the bone grafting needs of trauma, reconstructive, spine and extremity surgeons. The product expands with hydration to adapt to the contours of the surgical site. The company also introduced new meniscus allograft instrumentation, which have been improved based on surgeon recommendations.

Stryker launched the G-Lok implant into its VersiTomic portfolio for ACL/PCL reconstruction. The company says the VersiTomic G-Lok's rod design creates a spring-like action that allows the G-Lok to automatically deploy on the cortical surface. The device is designed to provide suspension fixation of soft tissue to bone during orthopedic reconstruction procedures.

DFINE announced the results of a study that suggests that cement augmentation using Radiofrequency Targeted Vertebral Augmentation (RF-TVA) with the DFINE StabiliT System may provide a lower leakage rate than vertebroplasty and balloon kyphoplasty in the treatment of VCFs. The study found that among post-operative radiographs of 101 consecutive patients treated with RF-TVA, vertebroplasty or kyphtoplasty, no leakage was reported in 69% of the RF-TVA group, 53% of the vertebroplasty group and 41% of the kyphoplasty group. All leaks identified were asymptomatic.

MEDICREA announced the launch of a pre-IDE pilot trial in the U.S. for its GRANVIA-C. The company describes the product as a next-generation cervical disc made from ceramic and offering six degrees of freedom, which it achieves through differentiated centers of rotation, and a "patented mobile core" with an "integrated shock absorber system." The product received CE mark certification in late 2009.

Email this to a colleague: